MAY 07, 2016 8:33 AM PDT

First Safe Way to Target Drugs to the Placenta

WRITTEN BY: Xuan Pham
Image credit: Pixabay.com

For the first time, scientist demonstrate an effective way to deliver drugs to the placenta – a feat that’s almost impossible to accomplish without harm to the baby. Key to this discovery was the scientists’ realization that the placenta has properties similar to tumors, and thus, drug delivery mechanisms that work in tumors could also work for the placenta. The team hopes this proof-of-concept study will pave the way for future therapies to prevent premature births and other pregnancy-related complications.
 
The placenta is a complex organ that develops in the uterus of pregnant women. It attaches to the uterine wall, and provides oxygen and nutrients to the growing baby via the umbilical cord that extends from it. In addition, the placenta keeps waste products from accumulating in the baby’s blood.
 
Given the important roles, the health of the placenta is crucial to the well-being of both mother and baby. In some instances when the placenta is not functioning properly, doctors are forced to induce early delivery – a procedure that significantly raises the risks of infant mortality and related complications.

Drugs available to treat complications in utero are severely limited because of their potential harm to the growing baby. The difficulty remained: how to exclusively target the organ without side-effects to the nearby tissues. In this sense, the team of researchers realized the problem is much similar to treating tumors without collateral damage to the body.
 
"Placentas behave like well-controlled tumors," said Lynda Harris, researcher at the University of Manchester in England, and senior study author. "They grow quickly, produce growth hormones and evade the immune system. A lot of cancer research focuses on finding ways of delivering drugs to kill the tumor without affecting the rest of the body. We had the idea that if we could selectively target the placenta in the same way, we could deliver other drugs to help improve placental function and therefore treat pregnancy complications."
 
Indeed, they cloaked a growth hormone in tumor-homing peptides, which are short chains of simple amino acids. The peptides act as a chaperone to guide the drug to only the placenta organ. In mouse studies, the team showed this method was effective at increasing the growth of undersized fetuses. Additionally, the drug did not accumulate in the mother mouse’s organs nor the fetus, suggesting the drug was highly specific to only the placenta.
 
"Our findings emphasize the similarities between placentas and tumors," said Erkki Ruoslahti, a distinguished adjunct professor at UC Santa Barbara. "That similarity makes it possible to take some of the existing tumor-homing peptides and make use of them in targeting drugs to the placenta. This paper shows that it is possible to increase the delivery of drugs into the placenta via these peptides."
 
Of note, the study demonstrated proof-of-concept for the targeted delivery of drugs to the placenta based on methods established in cancer therapies. "Only one drug for use during pregnancy has been licensed in the last 20 years," said Harris. "By developing this platform, we have opened up the possibility that any number of new drugs can be adapted and then used safely to treat common and serious pregnancy complications."

Additional source: UC Santa Barbara press release

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 05, 2020
Clinical & Molecular DX
Painless Microneedle Patch Diagnoses Malaria in Minutes
NOV 05, 2020
Painless Microneedle Patch Diagnoses Malaria in Minutes
It looks like a Band-Aid — a small, adhesive patch that is applied directly to the skin. This simple, low-cost dia ...
NOV 18, 2020
Clinical & Molecular DX
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
NOV 18, 2020
Nerve Damage as a Prognostic Marker for Rare Autoimmune Disease
Researchers have identified a new prognostic biomarker for Guillain-Barré syndrome (GBS), a rare autoimmune disor ...
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
DEC 08, 2020
Genetics & Genomics
Advancing Genetic Sequencing with Better Computational Tools
DEC 08, 2020
Advancing Genetic Sequencing with Better Computational Tools
The many advances that have propelled the field of genetics forward have taken a tremendous amount of work in different ...
JAN 14, 2021
Cardiology
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
JAN 14, 2021
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
The everyday tracking of health has become far easier these days with the advent of fitness watches and other technology ...
MAR 02, 2021
Clinical & Molecular DX
Splice and Dice: Zeroing in on Rare Gene Variants in Alzheimer's
MAR 02, 2021
Splice and Dice: Zeroing in on Rare Gene Variants in Alzheimer's
DNA is the four-letter language that codes for genes, “paragraphs” of DNA information that carry specific in ...
Loading Comments...